Primary care detection of cognitive impairment leveraging health and consumer technologies in underserved US communities: protocol for a pragmatic randomised controlled trial of the MyCog paradigm

INTRODUCTION: Early identification of cognitive impairment (CI), including Alzheimer’s disease and related dementias (ADRD), is a top public health priority. Yet, CI/ADRD is often undetected and underdiagnosed within primary care settings, and in health disparate populations. The MyCog paradigm is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovett, Rebecca, Bonham, Morgan, Yoshino Benavente, Julia, Hosseinian, Zahra, Byrne, Greg J, Varela Diaz, Maria, Bass, Michael, Yao, Lihua, Adin-Cristian, Andrei, Batio, Stephanie, Kim, Minjee, Sluis, Amanda, Moran, Margaret, Buchanan, David R, Hunt, Justin, Young, Stephanie R, Gershon, Richard, Nowinski, Cindy, Wolf, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
General practice / Family practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603543/
https://www.ncbi.nlm.nih.gov/pubmed/37852774
http://dx.doi.org/10.1136/bmjopen-2023-080101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603543/
https://www.ncbi.nlm.nih.gov/pubmed/37852774
http://dx.doi.org/10.1136/bmjopen-2023-080101

Ejemplares similares